echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > Yu Jintai's team found a new target for drug treatment for Alzheimer's disease

    Yu Jintai's team found a new target for drug treatment for Alzheimer's disease

    • Last Update: 2021-08-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Recently, the team of Professor Yu Jintai from the Department of Neurology of Huashan Hospital Affiliated to Fudan University comprehensively used a new multi-omics integrated research strategy to unearth seven genes such as ACE that can regulate Alzheimer’s disease to varying degrees at the transcription and expression levels ( AD) is expected to be a new drug treatment target for Alzheimer’s


    Senile dementia, including Alzheimer's disease, is a severe health challenge facing the world today.


    In order to effectively discover the drug targets of AD, the Yujintai team comprehensively used new multi-omics integrated research strategies such as genomics, transcriptomics and proteomics and a variety of machine learning methods to conduct research in the brain and serum specimens.


    The dorsolateral area of ​​the prefrontal cortex of the brain is the brain area affected by the AD core, and the expression levels of many AD-related genes in this area are up-regulated or down-regulated


    Compared with brain specimens, although the specificity of gene expression in peripheral blood is low, specimens are easy to obtain, so the research and development of genes or protein targets in peripheral blood is more valuable and maneuverable


    Yu Jintai said that this suggests that the expression of the ACE gene in peripheral blood still significantly affects the occurrence of AD and can be used as a potential drug target for the treatment of AD


    Related paper information: https://doi.


    https://doi.
    org/10.
    1038/s41380-021-01251-6
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.